Icon
+91 94997 68112
Login Register

Zymar - ( 0.3% ; Solution/Drops)

Gatifloxacin Allergan
0.3% ; Solution/Drops
Less Than $1000 mn
Less Than 5
Less Than 5
Less Than 5
Less Than 5
None None
Indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms:
Yes
****** *** *** ***** ** **** **** ** ** ****** '*** ******** ** *** **, **** & *** ************ *********. ***** ***** *** *** ****** ** ****** ** '*** ** ******* ****** ***** *. ***** ***** *** ******* **** ***** * **** ** ** ****** '***. ******* ***** **** ******** ***** *** ******* ******* ******** *** ****** '*** ** *******. ***** ** *** **** ****** '*** (**** *, ****) ** ***** *** ********* **** * **** ***. **** *** ********* *** ****** *** ******* ** **** *, ****. ****** ****** *** ********* ******** *** **** ** *** ***** ********* **** ******** ** ********* ******** *** ***** **** ****.
Zymar Patent 1 Patent 2
****** *** ** ** **** ***
***** *** ** ** (****** *******) **** ***
******* ******* **** ***
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
****** *** \ ** ***, **** *** ** ** ******** ************ *********
***** ** \ ** *** **, **** *** ** ** **** ****** **** ********
******* ** \ ** *** **, **** ******* **** ****** **** ********
  1. ***, **** : ***** & ******** ***** * **** ******* ****** ** ****** *** ***** * ****** **** *.*% ***** ********* ******** *** ****** ******* ** ******** ***** ** ********.
  2. ****, **** : ***** ***** **** ****** *** *** ****** ** ****** '*** **** ******* ****** *** ***** *, **** ***** ** ***** ********* *** ********* ** ***** * . ******** ******** ** ***** * *** ***** ** ****** '*** *** ***** ****** ** *** **** ** **** **** ****** *** **** ** *** **** ********* ****** *.*. ***** *.
  3. ***** *, **** : ***** ******** ******** ***** *** **** ** ****** *** ******* '***.
  4. *** **, **** : ***** & ******** ***** * **** ******* ***** ** ******** ***** ** ********.
  5. *** **, **** : ****** ******** ******** *** *** *** ****** *** ******* ****.
  6. *** **, **** : ******** ***** * ****** *** *********** ********* ********** * ****** **** ****** '*** ** ********* ** ******.
  7. ***** **, **** : ******* ******** ******** ***** *** **** *** ***** **** **** ** **** ****** '*** - *** **, ****.
  8. *** **, **** : ******** **** ******* ** ******** ** ********.
  9. *** *, **** : ***** ***** ** ***** ** ***** *** ******* ******** **** ****** '*** ** *******
  10. *** **, **** : ********'* ****** *** *********** ********* ** *********
  11. *** **, **** : ********** ********* **** *******
  12. *** **, **** : ******* ***** ******** ******** *****'* ******** ** '*** ******

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.